The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s cell therapy technologies market report forecasts the cell therapy technologies market size to grow to $7.39 Billion by 2027, with a CAGR (compound annual growth rate) of almost 15%.

Learn More On The Cell Therapy Technologies Market Report 2023 – https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Cell Therapy Technologies Market Size Forecast
The global cell therapy technologies market is expected to grow from $3.53 billion in 2022 to $4.24 billion in 2023 at a compound annual growth rate (CAGR) of 20.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The cell therapy technologies market size is expected to grow to $7.39 billion in 2027 at a CAGR of 14.9%.

North America held the largest cell therapy technologies market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Cell Therapy Technologies Market Driver ­– Increase In Investments By The Government In Cell-Based Research
For instance, in May 2022, The California Institute for Regenerative Medicine (CIRM), a research center helping stem cell research invested more than $11 million to fund a clinical trial for a cell therapy for the treatment of throat cancer. The success of this therapy will save patients from undergoing radiotherapy and its side effects.

Request for A Sample Of The Global Cell Therapy Technologies Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4122&type=smp

Key Cell Therapy Technologies Market Trend – Strategic Collaborations And Partnerships
Strategic collaborations and partnerships between the industry players are gaining popularity in the cell therapy technologies market. Major companies are collaborating and partnering with other companies to develop new technologies in cell therapy areas for the treatment of a variety of diseases. For instance, in August 2020, IsoPlexis Corporation, USA-based, collaborated with Lonza, a Switzerland-based chemicals and biotechnology company, to enable the next generation of precision cell therapy manufacturing. In another instance, in July 2020, Hitachi, Ltd., a Japan-based provider of a broad range of solutions including automated cell culture technologies to pharmaceutical companies in the area of cell therapy and regenerative medicine industry, collaborated with ThinkCyte, Inc., a Japan-based biotechnology company to focus on developing artificial intelligence (AI)-driven cell analysis and sorting system.

Cell Therapy Technologies Market Segment
1) By Product: Consumables, Equipment, Systems & Software
2) By Cell Type: T-cells, Stem Cells, Other Cells
3) By Process: Cell Processing, Cell Preservation, Distribution, and Handling, Process Monitoring and Quality Control
4) By End User: Life Science Companies, Research Institutes

Cell Therapy Technologies Market Major Players and Strategies
Major players in the cell therapy technologies market are Thermo Fisher Scientific, Merck, MaxCyte, Lonza Group, Sartorius, Terumo BCT, Fresenius Medical Care AG & Co. KGaA, Avantor Inc., Miltenyi Biotec, STEMCELL Technologies Inc., Beckman Coulter, Danaher, Becton Dickinson and Company, and GE Healthcare.

In March 2020, Danaher Corporation, a USA-based company that designs, manufactures, and markets professional, medical, industrial, and commercial products and services, acquired General Electric (GE) biopharma business for $21.4 billion. The biopharma business was a part of the GE life sciences division that offered software and equipment used in biopharmaceutical research. The acquisition is expected to expand Danahe’s life sciences business. General Electric Company is an American company that operates in four industrial segments: aviation, power, renewable energy, and healthcare globally.

The Cell Therapy Technologies Global Market Report 2023 covers regional data on cell therapy technologies market size, cell therapy technologies market trends and drivers, opportunities, strategies, and cell therapy technologies market competitor analysis. The countries covered in the cell therapy technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Cell therapy is a type of treatment in which active cells are injected into a patient’s body to treat certain disorders.This therapy seeks to treat diseases by altering certain sets of cells. In this technique, cells that originate from the patient or a donor are modified outside the body and then injected into the patient.

View More Reports Related To The Cell Therapy Technologies Market –
Cell Culture Consumables And Equipment Global Market Report 2023
Cell Culture Global Market Report 2023
Cell Therapy Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: